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Background-In patients with chronic heart failure there is no relation between cardiac output and symptom limited exercise tolerance measured on a bicycle or treadmill. Furthermore, the increase in cardiac output in response to treatment may not be matched by a similar increase in exercise tolerance. More important in determining exercise capability is blood flow to skeletal muscle. This implies that the reduction in skeletal muscle blood flow is not directly proportional to the reduction in cardiac output and that there are regional differences in blood flow in patients with heart failure.
Methods-Cardiac output and regional blood flow measured in 30 patients with chronic heart failure were compared with values obtained from 10 healthy controls. Measurements were made at rest and in response to treadmill exercise and were all made non-invasively.
ResultsCardiac output was lower in the patients at rest and during exercise. Blood flow in the superior mesenteric and renal arteries was also lower in the patients and represented a different proportion of cardiac output than in the controls. In response to exercise the increase in blood flow to the calf and therefore to skeletal muscle, was reduced in the patients. In the patients there was no correlation between resting cardiac output and blood flow in the superior mesenteric artery, renal artery, or calf.
Conclusions Another vascular bed that is likely to be important in determining patients' symptoms is that of the kidneys. Control of salt and water excretion, and therefore plasma volume and tissue oedema, is intimately linked to both the perfusion pressure and blood flow to the kidneys.
If, as seems likely, the combination of cardiac output and arteriolar tone controls regional blood flow, knowledge of this would help in our understanding of heart failure and its response to treatment. The distribution of cardiac output has been described in healthy people and patients with heart failure.56 These studies confirmed that there was a significant reduction in regional blood flow in the patients and the proposal was that this reduction in flow was in proportion to the reduction in cardiac output. However, the measurements were made with invasive techniques, which in themselves may alter haemodynamic variables.7 This and the fact that the dye dilution measurements of regional blood flow cannot be readily repeated limit their usefulness in assessing patients' response to treatment. The purpose of this study was to investigate with non-invasive techniques cardiac output and regional blood flow at rest and in response to exercise in patients with chronic heart failure and compare the results with values obtained in healthy controls.
Patients and methods

PATIENTS
Thirty patients with chronic heart failure (New York Heart Association grade II-II-) were studied. All had been in heart failure for at least six months. Their mean (SEM) age was 67 (2) years and 27 were men. Heart failure was caused by ischaemic heart disease Department of Medicine, University Hospital, Nottingham in 23 patients, rheumatic heart disease with mitral regurgitation and impaired left ventricular function in four patients, and three patients had a dilated cardiomyopathy. All the patients were treated with at least 80 mg of frusemide daily and the mean dose was 156 mg (range 80-750 mg). In addition seven of the patients were taking captopril in a dose of at least 25 mg three times daily.
Ten volunteers with a mean (SEM) age of 49 (4) 
BLOOD FLOW IN THE SUPERIOR MESENTERIC ARTERY
Mean (SEM) resting values of blood flow in the superior mesenteric artery were 332 (12) ml/min in the patients compared with 446 (40) ml/min in the controls (p < 0-02). In the patients this was 9-8% of cardiac output whereas in the controls it was 10-8% of cardiac output. Figure 2 shows the relation between resting blood flow in the superior mesenteric artery and resting cardiac output in the patients. The relation between the two variables failed to reach significance (r = 0-27, p = 0-15).
BLOOD FLOW IN THE RENAL ARTERY
Satisfactory renal artery Doppler waveforms were obtained in only 15 of the patients. The mean (SEM) value of blood flow in the renal artery in the patients was 317 (26) ml/min compared with 452 (50) ml/min in the controls (p < 0-01). On the assumption that blood flow to both kidneys was the same, total renal blood flow represented 21-8% ofcardiac output in the Renal artery blood flow (ml/min) Figure 3 Relation between resting cardiac output and bloodflow in the right renal artery in the 15 patients with heartfailure in whom a satisfactory Doppler signal was obtained.
controls whereas it was 18-6% in the patients. Figure 3 shows the lack of relation between renal artery blood flow and cardiac output in the patients (r = 0 38, p = 0-12).
CALF BLOOD FLOW
The mean (SEM) values of resting calf blood flow in the patients was 1 9 (0-1) ml/100 ml/min whereas in the controls it was 2-7 (0 3) ml/ 100 ml/min, p < 0-05. Figure 4 shows the mean (SEM) values ofcalfblood flow at rest and from three to 13 minutes after a submaximal treadmill exercise test to a similar workload in the patients and the controls. Both groups showed the expected increase in calf blood flow after exercise but this was less in the patients than in the controls (p < 0 02). Figure 5 shows the relation between resting values of cardiac output and calf blood flow in the patients. Again there was no obvious relation between these two variables (r = 0-32, p = 0-09). Calf blood flow (ml/100 ml/min)
Discussion
In this study we simultaneously measured cardiac output and regional blood flow in a group of patients with severe heart failure and compared the results with those in healthy controls. All the measurements were performed non-invasively. We showed, not surprisingly, that the patients with heart failure had lower values of cardiac output at rest and that the increase in cardiac output in response to low levels of treadmill exercise was considerably less than the controls. We also showed that blood flow to the gut, kidneys, and limbs was reduced in the patients. It might be expected that the reduced cardiac output of patients with heart failure would lead to the same reduction in blood flow to all organs. This does not seem to be the case and there is differential redirection of the cardiac output in heart failure. Not only were the absolute values of blood flow to the tissues reduced, but the proportion of cardiac output to the gut and kidneys was also reduced in the patients compared with the controls. This presumably occurs to maintain blood flow to the cerebral and coronary beds. Similarly blood flow to the calf, which consists predominantly of skeletal muscle, was also reduced at rest and after exercise. We did not assess the other regional blood flow responses Although the absolute values of cardiac output may not be important in determining symptoms it is likely that any treatment that has a beneficial effect will need to increase cardiac output. If symptomatic improvement is dependent upon increasing renal and skeletal muscle blood flow then this will be most likely to occur only by an increase in cardiac output and not by further redistribution of cardiac output. The measurement ofregional blood flow and cardiac output is likely therefore to be useful in evaluating new treatments for heart failure. Heart failure is characterised by important abnormalities of cardiac output and regional blood flow. Further investigation of these abnormalities will give us a better understanding of the pathophysiology of the disease. The use of non-invasive techniques similar to those we have described will permit measurements to be made in more patients with mild heart failure in whom invasive measurements may not be clinically justified and it will also permit frequent serial measurements to be made of the response to treatment.
